Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
Furfaro
Nicole
N
Seattle Rheumatology Associates, Seattle, USA.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D007262:Infusions, Intravenous; D009722:Nurse Practitioners / Q000458:organization & administration*; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D011292:Premedication / Q000379:methods / Q000451:nursing; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab